| Literature DB >> 30389725 |
David Rotter1, Heshan Peiris2, D Bennett Grinsfelder1, Alyce M Martin2, Jana Burchfield1, Valentina Parra3, Christi Hull1, Cyndi R Morales1, Claire F Jessup4, Dusan Matusica4, Brian W Parks5, Aldons J Lusis6, Ngoc Uyen Nhi Nguyen1, Misook Oh1,7, Israel Iyoke1, Tanvi Jakkampudi1, D Randy McMillan1,8, Hesham A Sadek1, Matthew J Watt9, Rana K Gupta10, Melanie A Pritchard11, Damien J Keating12,13, Beverly A Rothermel14,15.
Abstract
Increasing non-shivering thermogenesis (NST), which expends calories as heat rather than storing them as fat, is championed as an effective way to combat obesity and metabolic disease. Innate mechanisms constraining the capacity for NST present a fundamental limitation to this approach, yet are not well understood. Here, we provide evidence that Regulator of Calcineurin 1 (RCAN1), a feedback inhibitor of the calcium-activated protein phosphatase calcineurin (CN), acts to suppress two distinctly different mechanisms of non-shivering thermogenesis (NST): one involving the activation of UCP1 expression in white adipose tissue, the other mediated by sarcolipin (SLN) in skeletal muscle. UCP1 generates heat at the expense of reducing ATP production, whereas SLN increases ATP consumption to generate heat. Gene expression profiles demonstrate a high correlation between Rcan1 expression and metabolic syndrome. On an evolutionary timescale, in the context of limited food resources, systemic suppression of prolonged NST by RCAN1 might have been beneficial; however, in the face of caloric abundance, RCAN1-mediated suppression of these adaptive avenues of energy expenditure may now contribute to the growing epidemic of obesity.Entities:
Keywords: Down syndrome; RCAN1; adaptive thermogenesis; obesity; sarcolipin
Mesh:
Substances:
Year: 2018 PMID: 30389725 PMCID: PMC6280800 DOI: 10.15252/embr.201744706
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807